Get the Stockscreener App
61.20
1.34%
0.81
After Hours:
59.98
-1.22
-1.99%
Globus Medical Inc stock is traded at $61.20, with a volume of 1.14M.
It is up +1.34% in the last 24 hours and up +1.19% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$60.39
Open:
$60.2
24h Volume:
1.14M
Relative Volume:
0.87
Market Cap:
$8.27B
Revenue:
$2.51B
Net Income/Loss:
$185.56M
P/E Ratio:
45.67
EPS:
1.34
Net Cash Flow:
$517.59M
1W Performance:
-3.26%
1M Performance:
+1.19%
6M Performance:
-14.89%
1Y Performance:
-18.27%
1-Day Range:
$59.51
$61.24
1-Week Range:
$59.51
$64.32
52-Week Range:
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
61.20 | 8.16B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-28-25 | Resumed | Stifel | Hold |
| May-27-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
A Critical Juncture for Globus Medical Shares - AD HOC NEWS
How supply chain issues affect Globus Medical Inc. stockEarnings Miss & Long-Term Growth Plans - newser.com
Is Globus Medical Inc. stock attractive for ETFsRate Hike & Free Community Supported Trade Ideas - newser.com
Is Globus Medical Inc. a candidate for recovery playPortfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com
How forex fluctuations impact Globus Medical Inc. Class stockShare Buyback & Daily Oversold Bounce Ideas - newser.com
Is Globus Medical Inc. still worth holding after the dipJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Cambiar Investors LLC Buys 139,548 Shares of Globus Medical, Inc. $GMED - MarketBeat
Can Globus Medical Inc. Class stock attract ESG investmentsTreasury Yields & AI Powered Market Entry Ideas - newser.com
Strs Ohio Sells 48,464 Shares of Globus Medical, Inc. $GMED - MarketBeat
How Globus Medical Inc. (GM0N) stock compares with market leadersJuly 2025 Review & Entry Point Confirmation Signals - newser.com
Tools to monitor Globus Medical Inc. recovery probabilityMarket Movement Recap & Risk Controlled Swing Trade Alerts - newser.com
Is Globus Medical Inc. stock positioned for digital transformation2025 Sector Review & Real-Time Market Sentiment Reports - newser.com
Evaluating Globus Medical Inc. with trendline analysisTrade Entry Report & Long-Term Investment Growth Plans - newser.com
Can Globus Medical Inc. recover in the next quarterMarket Activity Report & Risk Controlled Daily Trade Plans - newser.com
Geneva Capital Management LLC Buys 249,141 Shares of Globus Medical, Inc. $GMED - MarketBeat
How buyback programs support Globus Medical Inc. Class stockWatch List & Real-Time Market Sentiment Reports - newser.com
How Globus Medical Inc. Class stock reacts to weak economy2025 Top Decliners & Safe Capital Growth Tips - newser.com
Will Globus Medical Inc. Class stock benefit from sector leadershipJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
Can Globus Medical Inc. stock deliver sustainable ROETrade Risk Assessment & Proven Capital Preservation Methods - newser.com
Globus Medical, Inc. $GMED Holdings Raised by Terril Brothers Inc. - MarketBeat
Using Bollinger Bands to evaluate Globus Medical Inc.Layoff News & Verified Short-Term Plans - newser.com
Globus Medical, Inc. $GMED Shares Sold by Bessemer Group Inc. - MarketBeat
How Globus Medical Inc. stock performs in high volatility markets2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Is Globus Medical Inc. stock supported by strong cash flowsAnalyst Downgrade & Free Long-Term Investment Growth Plans - newser.com
Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3 - Yahoo Finance
What dividend safety score for Globus Medical Inc. stockWeekly Market Outlook & Weekly Stock Performance Updates - newser.com
Globus Medical (GMED): Examining Valuation as Share Price Recovers but Remains Below Analyst Targets - Sahm
Is Globus Medical Inc. stock bottoming outDividend Hike & Real-Time Stock Movement Alerts - newser.com
Why Globus Medical Inc. stock appeals to analystsPortfolio Return Report & Smart Allocation Stock Tips - newser.com
Globus Medical Stock Looks CheapValue Trap or Treasure? - Trefis
Is Globus Medical Inc. (GM0N) stock ideal for retirement investors2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
EBITDA per share of Globus Medical Inc Class A – BER:GM0N - TradingView
Globus Medical (GMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - sharewise.com
Lightrock Netherlands B.V. Has $14 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) to Release Earnings on Thursday - MarketBeat
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):